Search

Search Constraints

You searched for: Author/Creator Feng, Rui

Search Results

94. CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune‐related bowel disease. Issue 2 (16th February 2020)